- Home
- STRW vs HBIO Comparison
STRW vs HBIO Comparison
Compare STRW & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRW
- HBIO
- Stock Information
- Founded
- STRW 2015
- HBIO 1901
- Country
- STRW United States
- HBIO United States
- Employees
- STRW N/A
- HBIO N/A
- Industry
- STRW Real Estate Investment Trusts
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- STRW Real Estate
- HBIO Industrials
- Exchange
- STRW Nasdaq
- HBIO Nasdaq
- Market Cap
- STRW 92.9M
- HBIO 93.3M
- IPO Year
- STRW N/A
- HBIO 2000
- Fundamental
- Price
- STRW $10.60
- HBIO $2.16
- Analyst Decision
- STRW Strong Buy
- HBIO
- Analyst Count
- STRW 1
- HBIO 0
- Target Price
- STRW $10.00
- HBIO N/A
- AVG Volume (30 Days)
- STRW 216.7K
- HBIO 163.5K
- Earning Date
- STRW 11-08-2024
- HBIO 11-07-2024
- Dividend Yield
- STRW 5.04%
- HBIO N/A
- EPS Growth
- STRW 23.40
- HBIO N/A
- EPS
- STRW 0.51
- HBIO N/A
- Revenue
- STRW $112,050,000.00
- HBIO $97,732,000.00
- Revenue This Year
- STRW N/A
- HBIO N/A
- Revenue Next Year
- STRW N/A
- HBIO $4.32
- P/E Ratio
- STRW $20.26
- HBIO N/A
- Revenue Growth
- STRW 14.46
- HBIO N/A
- 52 Week Low
- STRW $6.56
- HBIO $1.99
- 52 Week High
- STRW $12.90
- HBIO $5.56
- Technical
- Relative Strength Index (RSI)
- STRW 42.39
- HBIO 42.95
- Support Level
- STRW $10.06
- HBIO $2.07
- Resistance Level
- STRW $10.55
- HBIO $2.32
- Average True Range (ATR)
- STRW 0.63
- HBIO 0.12
- MACD
- STRW -0.07
- HBIO -0.00
- Stochastic Oscillator
- STRW 37.14
- HBIO 22.58
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.